Malin Almgren

Malin Almgren is an experienced professional with a strong background in health data sciences, research consultancy, and strategic partnerships. Currently serving as a Board Member for CombiGene, Redsense Medical, and Experia Nordic Oy, Almgren also holds the position of Chief Executive Officer at Schain Research, where a focus is placed on advancing knowledge in drug development through advanced analytics. Prior roles include Board Member at DP SERVICES AB and Director of Strategic Partnerships at TURN, along with an extensive research background as Assistant Professor at Karolinska Institutet. Almgren holds a PhD in Medicine from Karolinska Institutet and an MSc in Chemistry from Stockholm University.